Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

CV kristin Engebretsenfl2

220 views

Published on

  • Secret drink to lose belly fat naturally at home without exercise ★★★ https://tinyurl.com/bkfitness4u
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

CV kristin Engebretsenfl2

  1. 1. Kristin M Engebretsen 32956 County 24 Blvd • Cannon Falls, MN 55009 Phone: 507-261-6471 Email: Kristin.M.Engebretsen@HealthPartners.com, kmengebretsen@gmail.com EDUCATION June 1997 RAMSEY HOSPITAL Post-Doctorate Toxicology Residency June 1996 UNIVERSITY OF MINNESOTA Doctor of Pharmacy June 1992 ST. NORBERT COLLEGE Bachelor of Science, Chemistry CERTIFICATES AND LICENSURE 1996 – Present Minnesota Board of Pharmacy Pharmacist License #116136 2001 – Present Minnesota Board of Pharmacy-Preceptor Pharmacist Preceptor License #116136 2012 – Present Fellow of the American Academy of Clinical Toxicology (FAACT) 2007 – Present Diplomate of the American Board of Applied Toxicology (DABAT) 2007 – 2012 Certified Specialist in Poison Information (CSPI) American Association of Poison Control Centers 2008 – 2013 HAZMAT- Course Provider and Instructor 2000 – Present Advanced Cardiac Life Support Provider (ACLS) 2010 – 2012 Pediatric Advanced Life Support Provider (PALS) 2000 – Present Basic Life Support Provider (BLS)
  2. 2. Kristin Engebretsen, PharmD, DABAT PROFESSIONAL EXPERIENCE July 2000- Present CLINICAL TOXICOLOGIST Regions Hospital • Emergency Medicine Department • St. Paul, MN 55101 July 2014- CLINICAL PROFESSOR Present University of Minnesota • College of Pharmacy • Minneapolis, MN 55455 Jan 2001- CLINICAL ASSOCIATE PROFESSOR July 2014 University of Minnesota • College of Pharmacy • Minneapolis, MN 55455 Jan 2012- Present TOXTRENDS-TACTICAL RECOGNITION OF EMERGENCY NARCOTIC AND DRUG SYNDROMES (WWW.TOXTRENDS.COM) Twin Cities Toxicology Consortium –CEO/Chief Manager July 2008- Present MEDICAL TOXICOLOGY FELLOWSHIP ASSISTANT AND BOARD MEMBER Medical Toxicology Fellowship Program • Regions Hospital/Minnesota Regional Poison Control Center June 2013- DECISION EDITOR/Board Member- Journal of Medical Toxicology Present July 2014- TOXED Reviewer/Editor- Toxicology Database editor/reviewer Present July 2008- Present CLINICAL TOXICOLOGY CONSULTANT Children’s Hospitals and Clinics of Minnesota July1997- 2000 CLINICAL TOXICOLOGIST Product Safety Resources -St. Paul, MN Mar 1996- 1997 PHARMACIST Minnesota Regional Poison Control Center • Minneapolis, MN Feb 2004- 2006 INTERN Minnesota Regional Poison Control Center Jun 1988- 1992 INTERN Methodist Hospital • St. Louis Park • MN Summer-
  3. 3. Kristin Engebretsen, PharmD, DABAT 1991 INTERN Hazelton Laboratories • Madison • WI
  4. 4. Kristin Engebretsen, PharmD, DABAT PUBLICATIONS ABSTRACTS Katzung K, Stellpflug S, LeRoy J, Boley S, Holger J, Engebretsen KM. "Randomized Controlled Study Comparing High Dose Insulin (HDI) to Vasopressors or Combination Therapy in Refractory Toxin-Induced Cardiogenic Shock (TICS); Awarded both Oral presentation and Poster Presentation, 2016 ACMT Annual Scientific Meeting, Huntington Beach, CA March 17-20, 2016. Cole, JB, Ho J, Engebretsen KM, Stellpflug SJ, Orozco BS, Nystrom P. A Prospective Study of Ketamine versus Haloperidol for Severe Prehospital Agitation. Accepted for platform presentation at the North American Congress of Clinical Toxicology (NACCT) in San Francisco, California 2015. Bond M, Zantec N, Henry K, Engebretsen KM, Thomas A, Stellpflug S. Intravenous Fat Emulsion Does Not Significantly Alter Clotting Markers in Dabigatran-Treated Blood. Poster Presentation at the ACMT Annual Scientific Meeting, March 27-29, 2015 at Clearwater Beach, FL. Published in J of Med Toxicol March 2015. Peterson B, Glasrud K, Stellpflug S, Engebretsen K, Salzman J, Frascone RJ, Burnett A. Prehospital ketamine for chemical restraint: Administered dose versus intubation rate. Prehosp Emerg Care. 2014;18(1):142. National Association of EMS Physicians® 2014 Annual Meeting January 16- 17, 2014. Burnett AM, Panchal D, Engebretsen KM. Prehospital Ketamine does not prolong on-scene time compared to Haloperidol when used for Chemical Restraint. Poster Presentation, National Association of EMS Physicians® 2014 Annual Meeting January 16-17, 2014. Orozco BS, Evens ZN, Holger JS, Engebretsen KM, Stellpflug SJ. A swine model of severe propranolol toxicity permitting direct measurement of cerebral oxygen tension. Poster Presentation, American College of Medical Toxicology (ACMT), March 14-19, 2013. Engebretsen KM, Stellpflug SJ, Cole JB, Holger JS, Anderson CP. Vasopressors versus Placebo in Beta Blocker Toxicity in a Porcine Model. Clin Toxicol 2012. Poster Presentation, European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) Congress, London, UK, May 2012. Cole JB, Engebretsen KM, Stellpflug SJ, Holger JS: 10u/kg/hr is Better than 1u/kg/hr in a Blinded, Randomized Controlled Trial in Poison Induced Cardiogenic Shock. Clin toxicol 2011;49(6):515. Oral Presentation, North American College of Clinical Toxicology (NACCT), October 7-12, 2011. Holger JS, Engebretsen KM, Stellpflug SJ, Cole JB, Harris CR. High dose Insulin Case Series. Clin Toxicol 2010;48(6):613. Poster Presentation, North American College of Clinical Toxicology (NACCT), October 7- 12, 2010.
  5. 5. Kristin Engebretsen, PharmD, DABAT Stellpflug SJ, Fritzlar SJ, Cole JB, Engebretsen KM, Holger JS. Overdose of Diltiazem, Metoprolol, and Amiodarone Treated Successfully with Intravenous Fat Emulsion and High Dose Insulin in an Awake Patient. Clin Toxicol 2010;48(6):612. Poster Presentation, North American College of Clinical Toxicology (NACCT), October 7-12, 2010 Engebretsen KM, Ortega H: Lethal lead level in a Pediatric Patient Successfully Treated with Oral Succimer. Oral Presentation, North American College of Clinical Toxicology (NACCT), Occ Med Subspecialty. Poster Presentation, San Antonio, TX, 2009. Morgan M, Engebretsen KM, Holger JS, Stellpflug SJ, et al. Addition of a Vasopressor to High Dose Insulin in Dihydropyridine Overdose Does Not Improve Outcome. Poster Presentation, North American College of Clinical Toxicology (NACCT), San Antonio, TX 2009. Engebretsen KM, Ortega H: Lethal Lead Level in a Pediatric Patient Successfully Treated with Oral Succimer. Poster Presentation, North American College of Clinical Toxicology (NACCT), San Antonio, TX, 2009. Engebretsen KM, Holger JS, Harris CR. Therapeutic Misadventures of High Dose Insulin without Adverse Effects. Poster Presentation, North American College of Clinical Toxicology (NACCT), Toronto Canada, 2008 Engebretsen KM, Holger JS: Determining Mechanism of Intracellular Inotropy of High Dose Insulin in Toxin Induced Myocardial Depression. Poster Presentation, SAEM, Washington DC 2008. Engebretsen KM, Marini JJ, Holger JS: High Dose Insulin In Multiple Drug Overdose. Clin Tox, 2007, Poster Presentation, NACCT, New Orleans October 2007 Holger JS, Engebretsen KM, Fritzlar SJ, Patten LC and Harris CR: Insulin Versus Vasopressin and Epinephrine To Treat Beta-Blocker Toxicity. Oral Presentation, North American College of Clinical Toxicology (NACCT), Orlando, Florida; September 2005. DeBoer LG, Engebretsen KM, Harris CR: Paroxysmal Sympathetic Storm (Diencephalic Seizures) Following Methadone Overdose. Poster Presentation, European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) XXI International Congress, Barcelona, Spain. May, 2001 Engebretsen KM, Harris CR: Severe Hyponatremia with Resultant Noncardiogenic Pulmonary Edema and Cerebral Edema Secondary to Ecstasy Intoxication. Poster Presentation,European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) XXI International Congress, Barcelona, Spain. May, 2001 Harris CR, Engebretsen KM. Disposition of Acetaminophen Overdose Patients by Emergency Physicians.Poster Presentation, North American College of Clinical Toxicology (NACCT), Orlando, FL1998. Holger J, Harris C, Engebretsen K. Comparison of Physostigmine, Sodium Bicarbonate, and Hypertonic Saline in the Treatment of Experimental Diphenhydramine Toxicity Academ Emerg Med, Poster Presentation, SAEM, Washington DC 1997. Gualtieri J, Filandrinos D, Engebretsen K. α-Chloralose Poisoning: An unexpected Hazard for the Street Drug User . Poster Presentation, North American College of Clinical Toxicology (NACCT), St. Louis, Missouri,1997.
  6. 6. Kristin Engebretsen, PharmD, DABAT Filandrinos D, Gualtieri J, Engebretsen K. Fluid Loss and Water Intoxication Leading to Hyponatremia Status Epilepticus in Amoxicillin Overdose. Poster Presentation, North American College of Clinical Toxicology (NACCT), St. Louis, Missouri 1997. PUBLICATIONS: Articles Skoog, CA, Engebretsen, KM. Are vasopressors helpful in toxin induced cardiogenic shock? Clin Toxicol (Phila). 2017 Feb 3:1-20. doi: 10.1080/15563650.2017.1284329. [Epub ahead of print] PMID: 28152638 Nelson ZA, Engebretsen KM, Stellpflug SJ. What Can A Urine Drug Screening Immunoassay Really Tell Us? Journal of Pharmacy Practice; 2015 Apr 27. pii: 0897190015579611. Froberg BA, Levine M, Beuhler MC, Judge BS, Moore PW, Engebretsen KM, Mckeown NJ, Rosenbaum CD, Young AC, Rusyniak DE; On behalf of the ACMT Toxicology Investigators Consortium (ToxIC). Acute Methylenedioxypyrovalerone Toxicity. J Med Toxicol 2015 Jun; 11(2):185-94. doi: 10.1007/s13181- 014-0446-8. Burnett, AM, Engebretsen, KM. The Association between Intramuscular Ketamine given for Pre-hospital Chemical Restraint with Intubation and Hospital Admission. Am J Emerg Med. 2015 Jan;33(1):76-9. Burnett, AM, Engebretsen KM, Panchal D. The Administration of Pre-hospital Ketamine for Chemical Restraint does not Prolong On-Scene Times Compared to Haloperidol Based Sedation. Australasian Journal of Paramedicine, 2014. Cole JB, Stellpflug SJ, Engebretsen KM. Asystole Immediately following intravenous fat emulsion for overdose. J Med Toxicol. 2014 Feb 12.(Epub ahead of print) Critical care management of verapamil and diltiazem overdose with a focus on vasopressors: a 25-year experience at a single center. Holger JS, Engebretsen KM, Stellpflug SJ, Cole JB, Kerns W 2nd. Ann Emerg Med. 2014 Jan; 63(1):91-2. doi: 10.1016/j.annemergmed.2013.10.036. No abstract available. Dean BV, Stellpflug SJ, Burnett AM, Engebretsen KM. 2C or Not 2C: Phenethylamine Designer Drug Review. J Med Toxicol. 2013 Jun;9(2):172-8. Cole JB, Stellpflug SJ, Ellsworth H, Anderson CP, Adams AB, Engebretsen KM, Holger JS. A blinded, randomized, controlled trial of three doses of high-dose insulin in poison-induced cardiogenic shock. Clin Toxicol 2013;51(4):201-7. Brent JR, Wax PM, Schwartz T, Kleinschmidt KC, Engebretsen K, Buehler M. The Toxicology Investigators Consortium Case Registry—The 2010 Experience. J Med Toxicol 2011;7(4):266-276. Carr ME, Engebretsen KM, Ho B, Anderson CP. Tetrahydrozoline (Visine) concentrations in serum and urine during therapeutic ocular dosing: A necessary first step in determining an overdose. Clin Tox 2011; 49(9):810-814.
  7. 7. Kristin Engebretsen, PharmD, DABAT Stellpflug JS, Fritzlar SJ, Cole JB, Engebretsen KM, Holger JS. Response to Letter to the Editor on Article: Stellpflug JS, Fritzlar SJ, Cole JB, Engebretsen KM, Holger JS. Cardiotoxic overdose treated with Intravenous fat emulsion and high dose insulin in the setting of hypertrophic cardiomyopathy. J Med Toxicol.2011; 7(2):151-3. J Med Toxicol. Aug 2011. Holger JS, Stellpflug SJ, Cole JB, Harris CR, Engebretsen KM. High dose insulin in toxin-induced cardiogenic shock- a consecutive case series. Clin Toxicol 2011; 49(7):653-8. Stellpflug SJ, Fritzlar SJ, Cole JB, Engebretsen KM, Holger JS. Cardiotoxic Overdose Treated with Intravenous Fat Emulsion and High-Dose Insulin in the Setting of Hypertrophic Cardiomyopathy. J Med Toxicol. 2011; 7(2): 151-3. Engebretsen, KM , Kazmazarek K, Morgan JL, Holger JS. High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clin Tox. 2011 April–May 2011; 49 (4):277-283 Lam SW, Engebretsen KM, Bauer SR. Toxicology Today: what you need to know now. J Pharm Pract 2011 ; 24 (2): 174-188. Engebretsen KM, Morgan MW, Stellpflug SJ, Cole JB, Anderson CP, Holger JS. Addition of phenylephrine to high-dose insulin in dihydropyridine overdose does not improve outcome. Clin Toxicol (Phila). 2010 Oct;48(8):806-12. Erratum in: Clin Toxicol (Phila). 2010 Nov;48(9):965. Stellpflug SJ, Harris CR, Engebretsen KM, Cole JB, Holger JS. Intentional overdose with cardiac arrest treated with Intravenous fat emulsion and high dose insulin. Clin Toxicol 2010 March 48(3):227-9 Ablorh NA, Nitu F, Engebretsen K, Thomas DD, Holger JS. Insulin-dependent Rescue from Cardiogenic Shock is not Mediated by Phospholamban Phosphorylation. Clin Toxicol 2009 April 47(4): 296-302. Holger JS, Engebretsen KM, et al. High dose insulin for toxin induced myocardial shock. J Clin Toxicol 2009 April 47(4): 303-7. Holger JS, Engebretsen KM, Fritzlar SJ, et al. Insulin versus vasopressin and epinephrine to treat beta- blocker toxicity. J Clin Tox, 2007 May; 45(4):396 - 401 Holger JS, Engebretsen KM, Obetz CL, Kleven TL, Harris CR. A comparison of vasopressin and glucagon in beta-blocker induced toxicity. Clin Toxicol 2006; 44(1):45-51.
  8. 8. Kristin Engebretsen, PharmD, DABAT Engebretsen KM, Harris CR, Wood J. Cardiotoxicity and Late Onset Seizures with Citalopram Overdose. J Emerg Med. 2003 Aug;25(2):163-6 Holger JS, Harris CR, Engebretsen KM. Physostigmine, Sodium Bicarbonate, or Hypertonic Saline to Treat Diphenhydramine Toxicity. Veterinary and Human Toxicology, 2002 Feb; 44(1) 1-4. Kingston RL, Chen WL, Borron SW, Sioris LJ, Harris CR, Engebretsen KM. Chlorpyrifos: A Ten-Year US Poison Center Exposure Experience. Veterinary and Human Toxicology, 1999; 41(2):87-92. Publications: Book Chapters Engebretsen, KM. Euglycemic Insulin Therapy. In: Critical Care Toxicology 2nd Edition 2016. http://link.springer.com/referenceworkentry/10.1007/978-3-319-20790-2_178-1 Fernandez AL, DVM; Lee JA, DVM, DACVECC; Brutlag A., DVM; Hovda L, DVM, RPh, MS, DACVIM; Rahilly L, DVM, DACVECC; Engebretsen KM, PharmD, DABAT. SOAR: STATE-OF-THE-ART REVIEW. The use of intravenous lipid emulsions as an antidote in toxicology: a review. Journal of Veterinary Emergency and Critical Care 2011. Respiratory Pharmacology: In Respiratory Care Principles and Practice. Sioris K, Engebretsen, KM. Jones & Bartlett Learning, Sudbury MA, Copyright 2012. Engebretsen K, Sryring RS: Beta Andrenergic Receptor Antagonists. In: Blackwell’s Five-Minute Veterinary Consult (5MVC) Clinical Companions Small Animal Toxicology. Wiley-BlackWell 2010 . Sryring RS, Engebretsen K: Calcium Channel Receptor Antagonists. In: Blackwell’s Five-Minute Veterinary Consult (5MVC) Clinical Companions Small Animal Toxicology. Wiley-BlackWell 2010. Engebretsen K: Morphine. In: Harris CR (ed): Emergency Management of Selected Drugs of Abuse. Dallas, TX: ACEP Publishing, October 2000, pp 67-75. Engebretsen K: Methadone and LAAM. In: Harris CR (ed): Emergency Management of Selected Drugs of Abuse. Dallas, TX: ACEP Publishing, October 2000, pp 95-103. Engebretsen KM, Harris CR. Caffeine and Related Nonprescription Sympathomimetics. In: Ford MD, Delaney KA, Ling LJ, Erickson T (eds). Clinical Toxicology. Philadelphia: W.B. Saunders, 2000. GRANTS 2016 Identification of the mechanism of bupropion induced neurological and cardiovascular toxicity. Funded by the American Academy of Clinical Toxicology- Junior Investigator Award. Mentor.
  9. 9. Kristin Engebretsen, PharmD, DABAT 2016 Identification of the mechanism of bupropion induced neurological and cardiovascular toxicity. Funded by HealthPartners Institute. Primary Investigator. 2016 Resident and Fellow Research Grant. Funded by HealthPartners Health Professional education; HealthPartners Institute. 2016 Melendy Award. University of Minnesota. Student Research Award. Identification of the mechanism of bupropion induced neurological and cardiovascular toxicity. Mentor. Funded by the University of Minnesota College of Pharmacy. 2015 Effects of Methylene Blue on Mortality in a Porcine Model of Amlodipine Toxicity. Co- Investigator. Funded by HealthPartners Research Foundation and EMBRS 2014 Effect of Norepinephrine on Cerebral Oxygenation in a Porcine Model of Propranolol Toxicity After Maximization of High Dose Insulin (HDI) Therapy. Co-Investigator. Funded by HealthPartners Research Foundation 2013 AACT (American Academy of Clinical Toxicology) Junior Investigator Research Grant Award. A Randomized Controlled Study Comparing Haloperidol to Ketamine as a Chemical Restraint for Severe Agitation in a Pre-Hospital Setting. Senior Mentor/Co-Investigator. American Academy of Clinical Toxicology 2012 Pilot Study of Cerebral Perfusion in a Swine Model of Propranolol Toxicity. (The evaluation of High Dose Insulin and Vasopressors). Co-Investigator. Funded by HealthPartners Research Foundation. 2010 High Dose Insulin Dosing Study in Cardiogenic Shock. Co-Investigator. Funded by HealthPartners Research Foundation. 2008 Hypothermia versus Hyperbaric Treatment for Carbon Monoxide Toxicity. Co-Investigator. Funded by HealthPartners Research Foundation. 2007 Insulin versus Insulin plus phenylephrine in Nifedipine Overdose. Co-Investigator. Funded by HealthPartners Research Foundation. 2006 Determining Intracellular Mechanism of Insulin Inotropy in Myocardial Depression. Principle-Investigator. Funded by HealthPartners Research Foundation. 2005 American Academy of Clinical Toxicology Research Grant for Vasopressin and Epinephrine vs Insulin and glucose in Beta-Antagonist Toxicity in an Animal Model. Co-Investigator. Funded by HealthPartners Research Foundation
  10. 10. Kristin Engebretsen, PharmD, DABAT 2003 Vasopressin and Epinephrine vs. Insulin and Glucose in Beta-antagonist Toxicity in a Animal Model. Co-Investigator. Funded by HealthPartners Research Foundation. 2001 Vasopressin vs. Glucagon as an antidote in Beta-antagonist Toxicity in an Animal Model. Co- Investigator. Funded by HealthPartners Research Foundation. 1996 Physostigmine, Sodium Bicarbonate, or Hypertonic Saline to Treat Diphenhydramine Toxicity. Co-investigator. Funded by Regions Hospital Emergency Department Medicine Research Foundation MEDICAL-LEGAL CONSULTATION (Sample cases of Medical Legal/Expert Witness Testimony) 2016 Kerry Raymond- Best & Flanagan LLP- wrongful death and marijuana 2013 Mathew Mankey, Attorney at Law. “Roid Rage”- Criminal case involving anabolic steroid use. 2011 Ruth Lee, Attorney at Law, Minnesota Public Defender. Methadone and Benzodiazepine effects on driving. 2009 Bass Law Firm, Attorney at Law, Burnsville, MN. GHB and possible drug induced rape; LSD induced perceptual effects. 2008 Schneider, Schneider & Schneider, Attorney at Law, Fargo, North Dakota. Marijuana use and relationship to traumatic brain injury sustained at work. 2005 Leonard, Street and Deinard: Positive cocaine toxicology screen in a Healthcare Provider. 2003 Schneider, Schneider, & Schneider, Attorneys at Law, Fargo, North Dakota. Marijuana relationship in work related fatality. 2002 Rodli, Beskar, Boles & Krueger, S.C. Attorneys at Law Pharmacy Malpractice Suit: Dispensing Error Clonazepam filled for Clonidine 2001 Rodli, Beskar, Boles and Kruegar, S.C. – False Negative urinary toxicolgoy screen for clonazepam, Letter of expertise. 1999 Stimulant induced effects. Hennepin County Public Defender. 1999 SC Johnson-Client Liason and Consultant to SC Johnson Consumer and Professional: multiple consulting cases throughout the 2 years at PROSAR
  11. 11. Kristin Engebretsen, PharmD, DABAT 1999 Playtex – Toxicological consultant for multiple cases (mold growth in babybottles, dioxin toxicity and tampon use) 1998 “Possible Digoxin Overdose in an Infant: Death by overdose or natural causes”. Abbott Heart , Product Safty Resources. 1998 Aspirin Overdose-Medical Examiner case presentation, PROSAR. 1995 "Diphenhydramine Overdose”: Medical Examiner case presentation, Minnesota Regional Poison Center, Bloomington, Minnesota. TEACHING EXPERIENCE/INVITED GUEST LECTURING 11/16 Wisconsin Department of Safety and Professional Services Medical Examining Board Opioid Prescribing CME. Aspirus System-wide Grand Rounds CME On Demand website. Beyond smoking in the boys room current issues and challenges in toxicology. CME website: http://www.aspirus.org/Main/Continuing-Medical-Education.aspx#tab4 5/16 Grand Rounds Presentation: Beyond smoking in the boys room current issues and challenges in toxicology. Aspirus Hospital. Wausau, Wisconsin. Lecture for physicians and residents. 9/15 Invited guest lecture for “Divorce Camp”. Toxicology lecture for family law attorney’s on drugs of abuse. Craguns Resort, MN. 7/15 Invited guest panelist to review monograph data on glyphosate in regards to IARC has classification of glyphosate as a class 2A probable human carcinogen. Montreal, Canada July/August 2015. 3/15 Invited Guest to judge research at the EAPCCT conference in Sicily Italy. 1/15 Invited Guest Lecture: U of MN School of Pharmacy. Pharmacy Lunch with Guest Speaker. U of MN Pharmacy staff, alumni and students invited for guest lecture. 10/14 American Academy of Clinical Toxicology (AACT)- North American Congress of Clinical Toxicologists International Toxicology Conference: Vasopressors in Toxin Induced CV Shock. New Orleans, October 2014. 5/14 European Association of Poison Control Centres and Clinical Toxicolgoists (EAPCCT)- Invited Guest Speaker; Belgium Brussels-Gastrointestinal Decontamination. May 2014. 3/14 American College of medical Toxicology (ACMT)- National Midyear Meeting- Invited Critical Care Expert Panel; Tucson, AZ.
  12. 12. Kristin Engebretsen, PharmD, DABAT 2/14 Hennepin County Medical Center: Poison Hour: Drug abuse and pregnancy. Lecture for staff 11/13 Amery Hospital, Amery WI. Urine Drug Testing and Interpretation of laboratory testing. Lecture for staff. 9/13 American College of Medical Toxicology (ACMT)- North American Congress of Clinical Toxicologists, CSI Atlanta: Toxicology, Law Enforcement and Crime Scene Investigation. Atlanta Georgia, September 2013. Into the Wild 2: Pharmacological Management of Agitated Delirium. 9/13 North American Congress of Clinical Toxicology (NACCT): Critical Care Expert Panel. Atlanta Georgia, Sept 27-October 1, 2013. 5/12 European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) Congress, London, UK, May 2012. The Mechanisms by which High Dose Insulin Therapy is Effective in Calcium Channel and Beta Blocker Poisonings. 3/11 ACMT (American College of Medical Toxicolgoy) 9th Annual Spring Conference: Use of Antidotes in the Emergency Department. Invited Lecture: Clearwater, Florida. 2/11 AHLS: Advanced Hazmat Life Support: Provider Course. Lecture on Antidotes. 10/10 Emergency Medicine and Trauma Update. Focus on Toxicology. Minneapolis Airport Marriott, Bloomington, MN October 28th , 2010. 9/09 Update in Critical Care: University of Minnesota. “New Therapies in Toxicological Emergencies.” 6/09 Clinical Toxicology: A Critical Review and Update June 4th-5th Minneapolis Airport Marriott 4/09 Augsburg College, Physician Assistanct Guest Lecture: Toxicology Overview 2/09 Children’s Hospitals and Clinics- Pediatric Emergency Medicine Conference Update: “New Therapies in Toxicological Emergencies.” 10/08 St. John’s Hospital Intern Lecture: Acetaminophen Overdose 11/06 Herbal Lecture: “What works and What Doesn’t”- North Memorial Hospital. Guest Lecturer for Emergency Medicine Physicians Conference” 11/06 Herbal Lecture: “What works and What Doesn’t”-Hennepin County Medical Center. Guest Lecturer for Emergency Medicine Physicians/Poison Control Center Conference 10/05 Toxicology Symposium: Guest speaker at a 2 day symposium on Toxicology Provided by Healthpartners. This symposium is directed towards emergency medicine physicians and residents, family practice physicians and critical care or emergency nurses. Guest lecture for three lectures: Acetaminophen IV or Oral, New practices in Lithium overdose and CSI Toxicology (breakout Session)
  13. 13. Kristin Engebretsen, PharmD, DABAT 7/2005 Guest speaker for the Geriatrics Conference at Regions Hospital on Alternative Medicines and Geriatrics. Discussion of therapetic and toxicity concerns regarding herbals in the geriatric population. 6/2005 Guest Speaker for: Round Table Discussion : Hormone Replacement Therapy and Alterative Medicine Options for the Physicians of Family Health Services of MN. 5/2005 Toxicology Review: Tylenol induced Hepatic Failure: A CME accredited education program. Course Director. Conference for Emergency Medicine Physicians and University of Minnesota Surgeons. 2/2005 Occuational Medicine Annual Conference: Complementary and Alternative Medicine: What Works. Sheraton Hotel, St. Paul, MN 11/ 2003 Medical Education Program: Strategies in Hospital-Based Medicine. Regions Hospital. St. Paul, MN. 10/2003 Medical Education Program: Toxicology Review for Primary Care Physians. Offering an intensive 3 day program /Certified Medical Education n Toxicology for the 5 state region (Minnesota, WI, Iowa, North and South Dakota) 9/2003 PALS (Pediatric Advanced Life Support- Toxicology Lecture)-Waconia Hospital 1 hour program for physicians and nurses. 1997-2003 Clinical Assistant Professor: University of Minnesota School of Pharmacy, Patient Assessment: PharmD I, II, and III students 1998-2003 Clinical Assistant Professor: University of Minnesota School of Pharmacy- Patient Assessment for the Doctor of Pharmacy 4 Students. Teaching patient assessment to students obtaining their doctorate degree through non traditional means 12/2002 Augsburg College: Physicians Assistant Program- Clinical Toxicology Lecture: “The Good, The Bad & The Ugly.” 2/2001 Seniors as Teachers. In association with the University of Minnesota School of Medicine. Teaching of Medical students and Pharmacy students-assessment of patients. 11/2001 EMS Annual Trauma Conference: Redwing, MN. Drugs of abuse: An update. 2/2000 Psychiatry Grand Rounds- Drugs of Abuse. Asked to serve as a guest lecturer for physicians, nurses and health care practitioners at Regions Hospital. 12/2000 Hudson EMS- Guest lecture for Hudson’s EMS and physicians on Drugs of Abuse. 12/2000 Drugs of Abuse- Social Services, Regions Hospital. Served as a guest
  14. 14. Kristin Engebretsen, PharmD, DABAT lecture on Drugs of Abuse. 11/2000 EMS/Life Link Regional Educational Session 2000. New Drugs of Abuse. Served as a guest lecturer to educate EMS/paramedics/EMT’s, Nurses on new drugs of abuse. 1997-1999 Clinical Instructor: University of Minnesota School of Pharmacy, Clinical Toxicology Course PharmD III Students 1997-1999 Education and teaching of Pharmacy and Medical Students on Clinical Toxicology Rotation at the Minnesota Regional Poison Control Center, Regions Hospital and the International Poison Control Center at PROSAR. 5/97 “Career Opportunities and Poison Control Centers”, University of Minnesota, School of Pharmacy, Pharmacy students. 4/97 “Poisonings”-EMT training, Litchfield Minneseta, Emergency Medicine Technicians and Nurses, Litchfield Hospital. 2/97 “Phenytoin and Drug Induced Seizures”-Morning report, Ramsey Hospital, Medical students, Interns and Staff Physicians. PROFESSIONAL AFFILIATIONS 2012-Pesent Fellow of the North American Academy of Clinical Toxicology (FAACT) 1998-Present North American Congress of Clinical Toxicology (NACCT) member 2007-Present Diplomate of the Amerian Board of Applied Toxicology (DABAT) 2012-2018 American Board of Applied Toxicology (ABAT) –President Elect/President/Past President 2013-Present Journal of Medical Toxicology Editorial Board Member 2009-Present American Board of Applied Toxicology (ABAT)- Board Member 2009-Present American Board of Applied Toxicology (ABAT)-Chair/Co-Chair of the Education Committee 2009-2012 Amerian Board of Applied Toxicology (ABAT)– Co-Chair of the Scientific Affairs Committee. 2009-Present American Board of Applied Toxicology (ABAT) - Credentialing Committee 2012-Present American Academy of Applied Toxicology (AACT) –Education Committee 2010-2013 ToxIC-Toxicosurveillance Coordinator for the American College of Medical Toxicology 2012-Present American College of Medical Toxicology (ACMT) Affiliate Member 2012- Present American College of Medical Toxciology (ACMT) Affiliate Member Liason 2014-Present American College of Medical Toxicology (ACMT) Research Committee Member 2012-Present American Academay of Clinical Toxicology (AACT) –Education Committee Member 2005-Present Emergency Medicine Research Committee-Regions Hospital 2005-2013 Clinical Research Subcommittee-Vice Chair-Regions Hospital 2005-Present Pharmacy and Therapeutics Committee – Regions Hospital 2010-Present Pedatric Toxicology Interest Group: American Academy of Clinical Toxicology 2004.2006 Cannon Falls Chemical Education Board
  15. 15. Kristin Engebretsen, PharmD, DABAT ACADEMIC HONORS/AWARDS 2012 Election as President-elect for the American Board of Applied Toxicology (ABAT ) 2012 Awarded Fellow Status – American Academy Clinical Toxicology (FAACT) 2010 Award winner of the American Association of Poison Control Centers (AAPCC) Best Original Scientific Poster Award for the North American College of Clinical Toxicology (NACCT). 2006 Awarded Preceptor of the Year – University of Minnesota College of Pharmacy. 1992 Awarded All American Achievement Scholar – United States Achievement Academy (National) Volunteer/Community Service 2004.2006 Cannon Falls Chemical Education Board 2003-2004 Cannon Falls Community Food Shelf Board-Chairman REFERENCES AVAILABLE UPON REQUEST

×